Analysis of Long-Term Success and Biological Complications in Zygomatic Implant-Supported Prostheses.
Biological problems
long-term success
prostheses
tertiary care
zygomatic implants
Journal
Journal of pharmacy & bioallied sciences
ISSN: 0976-4879
Titre abrégé: J Pharm Bioallied Sci
Pays: India
ID NLM: 101537209
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
received:
27
03
2024
revised:
02
04
2024
accepted:
06
04
2024
medline:
30
9
2024
pubmed:
30
9
2024
entrez:
30
9
2024
Statut:
ppublish
Résumé
Patients with significant maxillary atrophy who are not candidates for standard implants now have an option thanks to zygomatic implants. Long-term statistics on difficulties and success are, however, scarce. A tertiary care center's patient data were retrospectively analyzed. Included were patients who underwent zygomatic implant surgery between 2017 and 2022. This research gathered and examined data on follow-up, surgical techniques, complications, demographics, and implant features. There were 100 patients in all. 92% of the implants were successful, and 92 of them survived. Peri-implantitis (20%), soft tissue dehiscence (15%), sinusitis (10%), prosthesis fracture (8%), and infection (5%), were among the biological consequences. In summary, zygomatic implants have the potential to help individuals with severe maxillary atrophy recover, but close observation and effective management of any problems are necessary to maximize results. To enhance patient care and improve treatment regimens, further research is required.
Identifiants
pubmed: 39346204
doi: 10.4103/jpbs.jpbs_308_24
pii: JPBS-16-2455
pmc: PMC11426578
doi:
Types de publication
Journal Article
Langues
eng
Pagination
S2455-S2457Informations de copyright
Copyright: © 2024 Journal of Pharmacy and Bioallied Sciences.
Déclaration de conflit d'intérêts
There are no conflicts of interest.